1. Home
  2. GABC vs PCRX Comparison

GABC vs PCRX Comparison

Compare GABC & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GABC
  • PCRX
  • Stock Information
  • Founded
  • GABC 1910
  • PCRX 2006
  • Country
  • GABC United States
  • PCRX United States
  • Employees
  • GABC N/A
  • PCRX N/A
  • Industry
  • GABC Major Banks
  • PCRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GABC Finance
  • PCRX Health Care
  • Exchange
  • GABC Nasdaq
  • PCRX Nasdaq
  • Market Cap
  • GABC 1.4B
  • PCRX 1.2B
  • IPO Year
  • GABC N/A
  • PCRX 2011
  • Fundamental
  • Price
  • GABC $36.88
  • PCRX $24.10
  • Analyst Decision
  • GABC Buy
  • PCRX Buy
  • Analyst Count
  • GABC 4
  • PCRX 9
  • Target Price
  • GABC $44.50
  • PCRX $29.89
  • AVG Volume (30 Days)
  • GABC 119.8K
  • PCRX 546.7K
  • Earning Date
  • GABC 07-28-2025
  • PCRX 07-29-2025
  • Dividend Yield
  • GABC 3.15%
  • PCRX N/A
  • EPS Growth
  • GABC N/A
  • PCRX N/A
  • EPS
  • GABC 2.43
  • PCRX N/A
  • Revenue
  • GABC $256,672,000.00
  • PCRX $702,772,000.00
  • Revenue This Year
  • GABC $44.97
  • PCRX $7.54
  • Revenue Next Year
  • GABC $5.76
  • PCRX $10.78
  • P/E Ratio
  • GABC $15.11
  • PCRX N/A
  • Revenue Growth
  • GABC 4.68
  • PCRX 3.08
  • 52 Week Low
  • GABC $32.61
  • PCRX $11.16
  • 52 Week High
  • GABC $47.08
  • PCRX $29.61
  • Technical
  • Relative Strength Index (RSI)
  • GABC 38.66
  • PCRX 36.99
  • Support Level
  • GABC $36.55
  • PCRX $23.99
  • Resistance Level
  • GABC $39.20
  • PCRX $24.90
  • Average True Range (ATR)
  • GABC 0.77
  • PCRX 0.88
  • MACD
  • GABC -0.20
  • PCRX -0.21
  • Stochastic Oscillator
  • GABC 12.45
  • PCRX 11.61

About GABC German American Bancorp Inc.

German American Bancorp Inc is a bank holding company. The lines of business include Retail and commercial banking business which involves attracting deposits from the general public and using those funds to originate consumer, commercial and agricultural, commercial and agricultural real estate, and residential mortgage loans. These core banking activities also include the sale of residential mortgage loans in the secondary market. Wealth management services which involve providing trust, investment advisory, brokerage and retirement planning services to customers. Insurance operations include the offering of a full range of personal and corporate property and casualty insurance products.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: